Skip to main content
Signal8

ZyVersa Therapeutics, Inc. (ZVSA) AI Dilution Summary

Updated Nov 4, 2026

Cash was $302,660 at 2026-03-31 against estimated monthly burn of $266,373. The company has an active ATM program with A.G.P./Alliance Global Partners, authorised to $1,397,396. Note principal of $1,000,000 is payable at maturity on 2027-02-27.